Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Enhancing Pediatric Outcomes through Evidence-Based Speech-Language Pathology Practices

Enhancing Pediatric Outcomes through Evidence-Based Speech-Language Pathology Practices

Introduction

In the realm of speech-language pathology, particularly when working with children, the importance of evidence-based practices cannot be overstated. The recent research titled "Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)" provides valuable insights that can be translated into improving therapeutic outcomes for children. While the study focuses on macitentan's safety in treating pulmonary hypertension, its methodological approach and findings offer lessons for practitioners aiming to enhance their skills and outcomes in pediatric speech-language pathology.

Key Takeaways from the Research

The study by McLaughlin et al. (2022) highlights several critical aspects of real-world data analysis that can be applied to speech-language pathology:

Implementing Research Insights in Speech-Language Pathology

Practitioners can enhance their skills and improve pediatric outcomes by integrating these research insights into their practice:

Encouraging Further Research

The study by McLaughlin et al. serves as a reminder of the value of continuous research in improving clinical practices. Speech-language pathologists are encouraged to engage in or support research initiatives that explore new therapeutic techniques, tools, and technologies. By contributing to the body of evidence, practitioners can help shape the future of speech-language pathology and ensure the best outcomes for children.

To read the original research paper, please follow this link: Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS).


Citation: McLaughlin, V. V., Channick, R., Kim, N. H., Frantz, R. P., McConnell, J. W., Melendres-Groves, L., Miller, C., Ravichandran, A., Rodriguez-Lopez, J., Brand, M., Leroy, S., Wetherill, G., & Chin, K. M. (2022). Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS). Pulmonary Circulation, 12, e12150. https://doi.org/10.1002/pul2.12150
Marnee Brick, President, TinyEYE Therapy Services

Author's Note: Marnee Brick, TinyEYE President, and her team collaborate to create our blogs. They share their insights and expertise in the field of Speech-Language Pathology, Online Therapy Services and Academic Research.

Connect with Marnee on LinkedIn to stay updated on the latest in Speech-Language Pathology and Online Therapy Services.

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP